SCHEMBL29979705

SCHEMBL29979705

CCS(=O)(=O)c1ccc(S(=O)(=O)Nc2ccccc2N2CCC(C)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.54
MCOLN3 Q8TDD5 2/20 0.54
PKM P14618 1/20 0.54
MCOLN2 Q8IZK6 1/20 0.52
MCOLN1 Q9GZU1 1/20 0.52
ALDH1A1 P00352 7/20 0.52
GAA P10253 5/20 0.47
MAPT P10636 3/20 0.47
MAPK1 P28482 2/20 0.47
KDM4E B2RXH2 2/20 0.47
POLB P06746 2/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KMT2A Q03164 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
MEN1 O00255 2/20 0.46
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23043711 1.00 L3MBTL1 (0.54) L3MBTL1MCOLN3PKMMCOLN2MCOLN1
SCHEMBL23057330 0.86 ALDH1A1 (0.62) L3MBTL1MCOLN3PKMMCOLN2MCOLN1
SCHEMBL29978353 0.84 L3MBTL1 (0.53) L3MBTL1MCOLN3PKMMCOLN2MCOLN1
SCHEMBL23044081 0.84 L3MBTL1 (0.53) L3MBTL1MCOLN3PKMMCOLN2MCOLN1
SCHEMBL23057145 0.84 L3MBTL1 (0.53) L3MBTL1MCOLN3PKMMCOLN2MCOLN1
SCHEMBL31036858 0.84 MCOLN3 (0.52) L3MBTL1MCOLN3PKMMCOLN2MCOLN1
SCHEMBL29978866 0.83 L3MBTL1 (0.55) L3MBTL1MCOLN3PKMMCOLN2MCOLN1
SCHEMBL23043604 0.83 L3MBTL1 (0.55) L3MBTL1MCOLN3PKMMCOLN2MCOLN1
SCHEMBL24871275 0.81 L3MBTL1 (0.55) L3MBTL1MCOLN3PKMMCOLN2MCOLN1
SCHEMBL23043731 0.80 MCOLN3 (0.51) L3MBTL1MCOLN3PKMMCOLN2MCOLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 L3MBTL1 794/4885MCOLN3 3/4885PKM 3754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.